U.S. flag

An official website of the United States government

NM_000489.6(ATRX):c.7156C>T (p.Arg2386Ter) AND Intellectual disability-hypotonic facies syndrome, X-linked, 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 1, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002283442.1

Allele description [Variation Report for NM_000489.6(ATRX):c.7156C>T (p.Arg2386Ter)]

NM_000489.6(ATRX):c.7156C>T (p.Arg2386Ter)

Gene:
ATRX:ATRX chromatin remodeler [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq21.1
Genomic location:
Preferred name:
NM_000489.6(ATRX):c.7156C>T (p.Arg2386Ter)
Other names:
R1528*
HGVS:
  • NC_000023.11:g.77520832G>A
  • NG_008838.3:g.270438C>T
  • NM_000489.6:c.7156C>TMANE SELECT
  • NM_138270.5:c.7042C>T
  • NP_000480.3:p.Arg2386Ter
  • NP_612114.2:p.Arg2348Ter
  • LRG_1153:g.270438C>T
  • NC_000023.10:g.76776310G>A
  • NM_000489.4:c.7156C>T
Protein change:
R2348*; ARG1528TER
Links:
OMIM: 300032.0008; dbSNP: rs122445099
NCBI 1000 Genomes Browser:
rs122445099
Molecular consequence:
  • NM_000489.6:c.7156C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_138270.5:c.7042C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Intellectual disability-hypotonic facies syndrome, X-linked, 1
Synonyms:
XLMR-HYPOTONIC FACIES SYNDROME; Mental retardation-hypotonic facies syndrome X-linked, 1; Smith Fineman Myers syndrome 1; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010663; MedGen: C4759781; Orphanet: 73220; Orphanet: 93970; Orphanet: 93971; Orphanet: 93972; Orphanet: 93973; Orphanet: 93974; Orphanet: 93975; OMIM: 309580

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0025726293billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 1, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Inherited germline ATRX mutation in two brothers with ATR-X syndrome and osteosarcoma.

Ji J, Quindipan C, Parham D, Shen L, Ruble D, Bootwalla M, Maglinte DT, Gai X, Saitta SC, Biegel JA, Mascarenhas L.

Am J Med Genet A. 2017 May;173(5):1390-1395. doi: 10.1002/ajmg.a.38184. Epub 2017 Mar 28.

PubMed [citation]
PMID:
28371217
PMCID:
PMC7521841

Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).

Gibbons RJ, Picketts DJ, Villard L, Higgs DR.

Cell. 1995 Mar 24;80(6):837-45.

PubMed [citation]
PMID:
7697714
See all PubMed Citations (4)

Details of each submission

From 3billion, SCV002572629.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by less than 10%. The variant has been observed in at least two similarly affected unrelated individuals (PMID: 24690944 , 28371217 , 7697714). The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000011728 / PMID: 7697714). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 1, 2024